These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8936348)

  • 1. Amyotrophic lateral sclerosis: the involvement of intracellular Ca2+ and protein kinase C.
    Krieger C; Lanius RA; Pelech SL; Shaw CA
    Trends Pharmacol Sci; 1996 Mar; 17(3):114-20. PubMed ID: 8936348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis.
    Lanius RA; Paddon HB; Mezei M; Wagey R; Krieger C; Pelech SL; Shaw CA
    J Neurochem; 1995 Aug; 65(2):927-30. PubMed ID: 7616256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular mechanism of glutamate receptors in relation to amyotrophic lateral sclerosis.
    Iwasaki Y; Ikeda K; Kinoshita M
    Curr Drug Targets CNS Neurol Disord; 2002 Oct; 1(5):511-8. PubMed ID: 12769603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate, excitotoxicity and amyotrophic lateral sclerosis.
    Shaw PJ; Ince PG
    J Neurol; 1997 May; 244 Suppl 2():S3-14. PubMed ID: 9178165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS IgGs suppress [Ca2+]i rise through P/Q-type calcium channels in central neurones in culture.
    Andjus PR; Khiroug L; Nistri A; Cherubini E
    Neuroreport; 1996 Aug; 7(12):1914-6. PubMed ID: 8905691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis.
    Vermeiren C; Hemptinne I; Vanhoutte N; Tilleux S; Maloteaux JM; Hermans E
    J Neurochem; 2006 Feb; 96(3):719-31. PubMed ID: 16371010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylinositol 3-kinase: increased activity and protein level in amyotrophic lateral sclerosis.
    Wagey R; Pelech SL; Duronio V; Krieger C
    J Neurochem; 1998 Aug; 71(2):716-22. PubMed ID: 9681462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Death of motor neurons and molecular change of glutamate receptors in ALS].
    Shin K
    Rinsho Shinkeigaku; 2005 Nov; 45(11):982-4. PubMed ID: 16447780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit.
    Kimura F; Smith RG; Delbono O; Nyormoi O; Schneider T; Nastainczyk W; Hofmann F; Stefani E; Appel SH
    Ann Neurol; 1994 Feb; 35(2):164-71. PubMed ID: 8109897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium dysregulation in amyotrophic lateral sclerosis.
    Grosskreutz J; Van Den Bosch L; Keller BU
    Cell Calcium; 2010 Feb; 47(2):165-74. PubMed ID: 20116097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
    Heath PR; Shaw PJ
    Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis.
    Dangoumau A; Veyrat-Durebex C; Blasco H; Praline J; Corcia P; Andres CR; Vourc'h P
    Int J Neurosci; 2013 Jun; 123(6):366-74. PubMed ID: 23289752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS.
    Chang Q; Martin LJ
    Neurobiol Dis; 2016 Sep; 93():78-95. PubMed ID: 27151771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis.
    Appel SH; Smith RG; Alexianu M; Siklos L; Engelhardt J; Colom LV; Stefani E
    Clin Neurosci; 1995-1996; 3(6):368-74. PubMed ID: 9021258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitotoxicity and amyotrophic lateral sclerosis.
    Van Damme P; Dewil M; Robberecht W; Van Den Bosch L
    Neurodegener Dis; 2005; 2(3-4):147-59. PubMed ID: 16909020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium homeostasis in fibroblasts from patients with amyotrophic lateral sclerosis.
    Witt MR; Gredal O; Dekermendjian K; Undén M; Nielsen M
    J Neurol Sci; 1994 Nov; 126(2):206-12. PubMed ID: 7853028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-dependent protein folding in amyotrophic lateral sclerosis.
    Prell T; Lautenschläger J; Grosskreutz J
    Cell Calcium; 2013 Aug; 54(2):132-43. PubMed ID: 23764168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]phorbol 12,13-dibutyrate/PKC binding in thoracic spinal cord: no change in amyotrophic lateral sclerosis.
    Krieger C; Jacques D; Parent A; Quirion R
    Neuroreport; 1995 Jul; 6(10):1381-4. PubMed ID: 7488729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cu/Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of mitochondria and perturbs Ca2+ homeostasis in SOD1G93A mice.
    Jaiswal MK; Keller BU
    Mol Pharmacol; 2009 Mar; 75(3):478-89. PubMed ID: 19060114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.